Wound dressing player Acuron has successfully completed its back-door listing through the shell of former diamond miner Auridiam.
It raised $4.2 million through the capital raising linked with the relisting.
Acuron has also acquired advanced wound care company Vacutex, its key product, and secured exclusive distribution rights for the retractable needle syringe system and anti-needlestick sharps pads produced by SafeGard Medical products.
Vacutex is a patented wound dressing technology that has been given its own classification by the UK National Health Serviceand has a proven ability to reduce medical costs through accelerated healing, less frequent dressing changes and earlier patient discharge from hospital.
Acuron has begun to market two complementary products VacuSkin and VacuNet.